“Basel has all the ingredients required to host a successful company” The physician and pharmacologist Nicole Onetto is a member of the Board of Directors at…Jérémie Meyer06.11.2018
Meet the BaseLaunch Startups Six of the BaseLaunch startups recently started Phase II. They received either grants up to…Jérémie Meyer03.11.2018
BioMedPartners closes new venture capital fund Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at…Jérémie Meyer03.06.2018
BaseLaunch up to a solid Phase II start BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving…Jérémie Meyer01.30.2018
Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation,…Jérémie Meyer01.18.2018
Patient Data – Faster but with Respect and Trust “Faster but with Respect and Trust“ - these were the final words from Effy Vayena…Jérémie Meyer09.14.2017
Halozyme Therapeutics opens European headquarters Halozyme, a U.S. biotechnology company developing novel oncology and drug-delivery therapies, has established their European…Jérémie Meyer09.05.2017
3D im Spital Wo der 3D-Druck bereits heute standardmässig eingesetzt wird, in welche Richtungen sich die Technik entwickelt…Jérémie Meyer08.24.2017
Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss…Jérémie Meyer07.25.2017
Investing in strengths – Swiss leadership in life sciences How can Switzerland and the Basel region maintain their international leadership role in life sciences?…Jérémie Meyer05.15.2017